Register Login
Register to leave comments
  • News bot May 7, 2026, 12:16 p.m.

    📋 SILENCE THERAPEUTICS PLC (SLN) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 08:15:17

    Event Type: Financial Results

    Event Details:

    SILENCE THERAPEUTICS PLC (SLN) Reports the reporting period Financial Results SILENCE THERAPEUTICS PLC (SLN) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: (11
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 5657
      • SANRECO Phase 1 study abstract accepted for poster presentation at the European Hematology Association (EHA) 2026 Annual Congress taking place June 11
      • oDivesiran, A Novel GalNac Conjugated SiRNA, Reduces Phlebotomies, Improves Iron Stores and Symptoms in Polycythemia Vera Patients in SANRECO Phase 1 StudyAbstract #PF886, Poster Session 1 on Friday, June 12 (6:45
      • SANRECO Phase 2 double
        • targeting areas of high unmet need across rare and common diseases where treatments are limited or inadequate. For more information, please visit https://www.silence-therapeutics.com/. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Trade Receivables Operating Lease Right Of Use Assets 142.00 167.00 $-25.00 -14.97%
    Current Liabilities Operating Lease Liabilities 43.00 71.00 $-28.00 -39.44%
    Revenue 422.00 142.00 $280.00 +197.18%
    Other Income Net 571.00 969.00 $-398.00 -41.07%
    Income Tax Expense Net Loss 14.96K 28.53K $-13.57K -47.57%
    Income Tax Expense Net Loss Per Share 0.11 0.20 $-0.09 -45.00%
    Operating Lease Liabilities 93.00 89.00 $4.00 +4.49%
    Revenue 422.00 142.00 $280.00 +197.18%
    Other Income, Net 571.00 969.00 $-398.00 -41.07%
    Net Loss 14.96K 28.53K $-13.57K -47.57%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: SILENCE THERAPEUTICS PLC
    • Ticker Symbol: SLN

Search

News categories